Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
10/23/2002 | CN1375302A Ketangwan pills as diabetes treating medicine capable of inducing insulin synthesis and its prepn. |
10/23/2002 | CN1375297A Hircus treating medicament |
10/23/2002 | CN1375296A Coma treating composition medicine and its usage |
10/23/2002 | CN1375295A Functional water containing antioxidant radical natural medicament component and its production process |
10/23/2002 | CN1092984C Toad skin mixture for treating hepatitis B |
10/23/2002 | CN1092983C Lidan (leopard cat gall) lozerge |
10/23/2002 | CN1092982C Medicine for treating hyperosteogeny |
10/23/2002 | CN1092979C Process for preparing multi-strain antibody from water fowls |
10/23/2002 | CN1092978C Oral liquid for curing ganopathy |
10/23/2002 | CN1092974C Chinese medicinal food |
10/23/2002 | CN1092972C Medicine for resisting tumor and carcinomatosis |
10/23/2002 | CN1092971C Chinese medicine for treating rheumatism |
10/23/2002 | CN1092970C Compound Chinese medicine for treating hepatocholepathy |
10/23/2002 | CN1092968C Pharmaceuticals for treating outer skin blood vessel disease in cold seasons |
10/23/2002 | CN1092967C Powdered medicine for treating simple baby diarrhea |
10/23/2002 | CN1092966C Lactobacillus ointment for treatment of vaginal diseases and preparation method therefor |
10/23/2002 | CN1092965C Gause julid table for gastrosis and its preparing process |
10/23/2002 | CN1092964C Supercritical multiple bee glue extracting process |
10/22/2002 | US6469053 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
10/22/2002 | US6468962 Nutritional intervention composition for enhancing and extending satiety |
10/22/2002 | US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases |
10/22/2002 | US6468794 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
10/22/2002 | US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease |
10/22/2002 | US6468782 Cells are cultured or incubated under conditions sufficient to induce intracellular trehalose, suspended in stabilizing solution and dried to form a solid glass; storage stablility |
10/22/2002 | US6468778 Process for the inactivation of viruses |
10/22/2002 | US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer |
10/22/2002 | US6468544 Genetically engineered influenza a virus with an interferon-inducing phenotype wherein said virus comprises a viral genome wherein the complete ns1 coding sequences have been deleted (delns1). |
10/22/2002 | US6468527 Biological bioadhesive composition and methods of preparation and use |
10/22/2002 | US6468526 For therapy of vaginal and gastrointestinal infections |
10/22/2002 | CA2185712C Enhanced virus-mediated dna transfer |
10/22/2002 | CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor |
10/22/2002 | CA2084093C Composite molecular system for the contra-escalatory treatment of viral infections |
10/22/2002 | CA1341395C Preparation of functional human factor viii |
10/17/2002 | WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
10/17/2002 | WO2002081687A2 Yeast genes that affect viral replication |
10/17/2002 | WO2002081677A2 Improved gene expression |
10/17/2002 | WO2002081663A1 Process for producing nerve stem cells, motor neurons and gabaergic neurons from embryonic stem cells |
10/17/2002 | WO2002081660A1 Compositions and method for enhancing proteoglycan production |
10/17/2002 | WO2002081646A2 Epitope sequences |
10/17/2002 | WO2002081521A2 Osteoprotegerin in milk |
10/17/2002 | WO2002081513A2 Disease-associated protein |
10/17/2002 | WO2002081007A2 Methods of isolating blood components using a centrifuge and uses thereof |
10/17/2002 | WO2002080995A1 Scaffold matrix and tissue maintaining systems |
10/17/2002 | WO2002080983A1 Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins |
10/17/2002 | WO2002080982A2 Nucleic acid mucosal immunization |
10/17/2002 | WO2002080972A1 Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes |
10/17/2002 | WO2002080947A1 Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same |
10/17/2002 | WO2002080946A1 Compositions for preventing and/or treating oral diseases |
10/17/2002 | WO2002080945A2 Methods for treating the inflammatory component of a brain disorder |
10/17/2002 | WO2002080944A1 Topical analgesics and methods of use |
10/17/2002 | WO2002080933A1 A drug for use in bone grafting |
10/17/2002 | WO2002080921A1 Composition for inhibiting hiv activity extracted from paecilomyces sp. (tochu-kaso) j300 |
10/17/2002 | WO2002080861A1 Method for preparing a treatment product and a treatment product |
10/17/2002 | WO2002080851A2 Chimeric vaccines |
10/17/2002 | WO2002080681A1 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
10/17/2002 | WO2002062969A9 Cellular reprogramming in peptide hydrogel and uses thereof |
10/17/2002 | WO2002056897A3 Pharmaceutical for stimulating the regeneration of tissues |
10/17/2002 | WO2002054851A3 Inhibition of pathological angiogenesis in vivo |
10/17/2002 | WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
10/17/2002 | WO2002036146A3 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
10/17/2002 | WO2002009645A3 Intercellular transport protein linked to an antigen as a molecular vaccine |
10/17/2002 | WO2002000871A3 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
10/17/2002 | WO2001098344A3 Angiogenesis-modulating compositions and uses |
10/17/2002 | WO2001081551A3 Retinal pigment epithelial cell lines with extended life-span and their applications |
10/17/2002 | WO2001074404A3 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor |
10/17/2002 | WO2001060391A9 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
10/17/2002 | WO2001058922A9 Method and compositions for treating hepatocellular cancer |
10/17/2002 | WO2001056379A9 A method of quieting a corneal inflammatory response |
10/17/2002 | WO2001052878A9 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
10/17/2002 | WO2001040497A3 Method for obtaining nucleic acids from an environment sample |
10/17/2002 | US20020152490 Tolerance-inducing thy-marrow composite tissue construct and organ |
10/17/2002 | US20020152488 Genetically engineered animals for use as organ donors |
10/17/2002 | US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
10/17/2002 | US20020152481 Genetic engineering; qualitative analysis |
10/17/2002 | US20020151695 Transforming growth factor-beta-related molecules and uses thereof |
10/17/2002 | US20020151516 Carrier:nucleic acids complexes containing nucleic acids encoding anti-angiogenic peptides and their use in gene therapy |
10/17/2002 | US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
10/17/2002 | US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV |
10/17/2002 | US20020151067 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
10/17/2002 | US20020151066 Propagating cells which generate preferential neurotransmitters; obtain premature neuronal cells, transform with vector, express polypeptide, monitor cells and evaluate for neurotransmitter phenotype |
10/17/2002 | US20020151065 Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor |
10/17/2002 | US20020151056 Inducing cell differentiation in embryonic cells; obtain cells, inoculate nutrient broths, propagate cells, recover cells |
10/17/2002 | US20020151055 Novel artificial pancreas |
10/17/2002 | US20020151054 Cellular production control |
10/17/2002 | US20020151053 Generation of preferential cells in culture; generate nutrient broth, inoculate with cells, propagate, recover preferential cells |
10/17/2002 | US20020151050 Isolation of spore-like cells from tissues exposed to extreme conditions |
10/17/2002 | US20020151032 Generation of preferential viral vector; obtain cell, incubate with viral nucleotide sequences, propagate, recover nucleotide sequences |
10/17/2002 | US20020150986 Extracellular matrix signalling molecules |
10/17/2002 | US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases |
10/17/2002 | US20020150950 Solid phase quenching systems |
10/17/2002 | US20020150753 Porous, biodegradable polymer; tissue culture |
10/17/2002 | US20020150631 Methods of treating prion disease in mammals |
10/17/2002 | US20020150603 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
10/17/2002 | US20020150581 Compositions and methods for the therapy and diagnosis of breast cancer |
10/17/2002 | US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass |
10/17/2002 | US20020150562 Viral preparations, vectors, immunogens, and vaccines |
10/17/2002 | US20020150560 Treatment of Il-10 deficiencies |
10/17/2002 | CA2446462A1 Chimeric vaccines |
10/17/2002 | CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
10/17/2002 | CA2443275A1 Improved gene expression |